Cell Impact AB
Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells and electrolyzers in the United States, Sweden, Other Europe, and Asia. The company offers production series of flow plates; design for manufacturing and other design services; tools and prototypes; local production; and leak testing, cleaning options, and advanced measurement instruments. The company was inc… Read more
Cell Impact AB (CI) - Total Liabilities
Latest total liabilities as of September 2025: Skr29.21 Million SEK
Based on the latest financial reports, Cell Impact AB (CI) has total liabilities worth Skr29.21 Million SEK as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cell Impact AB - Total Liabilities Trend (2008–2024)
This chart illustrates how Cell Impact AB's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cell Impact AB Competitors by Total Liabilities
The table below lists competitors of Cell Impact AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Neith Corporation
TWO:6236
|
Taiwan | NT$13.40 Million |
|
Polaris Investama Tbk
JK:PLAS
|
Indonesia | Rp31.27 Billion |
|
SAMYUNG ENC Co. Ltd
KQ:065570
|
Korea | ₩36.82 Billion |
|
KWESST Micro Systems Inc. Common Stock
NASDAQ:KWE
|
USA | $2.80 Million |
Liability Composition Analysis (2008–2024)
This chart breaks down Cell Impact AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cell Impact AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cell Impact AB (2008–2024)
The table below shows the annual total liabilities of Cell Impact AB from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr42.16 Million | -46.33% |
| 2023-12-31 | Skr78.56 Million | +1.81% |
| 2022-12-31 | Skr77.17 Million | -19.70% |
| 2021-12-31 | Skr96.10 Million | +134.46% |
| 2020-12-31 | Skr40.99 Million | +215.67% |
| 2019-12-31 | Skr12.98 Million | -31.45% |
| 2018-12-31 | Skr18.94 Million | +192.67% |
| 2017-12-31 | Skr6.47 Million | -41.68% |
| 2016-12-31 | Skr11.10 Million | +108.17% |
| 2015-12-31 | Skr5.33 Million | +72.98% |
| 2014-12-31 | Skr3.08 Million | -5.38% |
| 2013-12-31 | Skr3.26 Million | -10.91% |
| 2012-12-31 | Skr3.66 Million | -38.66% |
| 2011-12-31 | Skr5.96 Million | -62.58% |
| 2010-12-31 | Skr15.93 Million | +318419.22% |
| 2009-12-31 | Skr5.00K | -62.09% |
| 2008-12-31 | Skr13.19K | -- |